Towa Pharmaceutical Co., Ltd.
4553.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥145 | ¥147 | ¥132 | ¥165 |
| - Cash | ¥50 | ¥35 | ¥45 | ¥29 |
| + Debt | ¥236 | ¥238 | ¥232 | ¥223 |
| Enterprise Value | ¥332 | ¥350 | ¥319 | ¥359 |
| Revenue | ¥65 | ¥65 | ¥66 | ¥70 |
| % Growth | 0.3% | -1.1% | -6.4% | – |
| Gross Profit | ¥24 | ¥24 | ¥24 | ¥26 |
| % Margin | 36% | 36.3% | 36.4% | 36.7% |
| EBITDA | ¥14 | ¥10 | ¥9 | ¥17 |
| % Margin | 21.8% | 16% | 14.2% | 24.3% |
| Net Income | ¥6 | ¥3 | ¥4 | ¥8 |
| % Margin | 8.7% | 3.9% | 6.6% | 11.5% |
| EPS Diluted | 115.81 | 51.05 | 88.61 | 163.92 |
| % Growth | 126.9% | -42.4% | -45.9% | – |
| Operating Cash Flow | ¥8 | ¥6 | ¥18 | -¥3 |
| Capital Expenditures | -¥8 | -¥4 | -¥7 | -¥10 |
| Free Cash Flow | -¥0 | ¥2 | ¥11 | -¥13 |